Kubler, H;van Randenborgh, H;Treiber, U;Lehmer, A;Wagenpfeil, S;Hartung, R;Paul, R.Combined application of imatinib and standard chemotherapeutics results in additive cytotoxic effects in human prostate cancer cell lines..J Clin Oncol.2004.22 Suppl..14.440S-440S